Arm-hand BOOST therapy to improve recovery after stroke
Official title: Aha BOOST Arm-hand BOOST Therapy to Enhance Recovery After Stroke: Clinical, Health Economic and Process Evaluation
Run by KU Leuven · NCT06517251 · Data updated 2026-11-12
This study is testing if a new arm-hand therapy can help people recovering from a stroke get better faster compared to a standard treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | KU Leuven Academic / other |
| Locations | 2 sites (Edegem, Antwerpen and 1 other locations) |
| Status | Recruiting |
| Started | June 17, 2024 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT06517251 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have experienced a first-ever unilateral stroke within the last five months and have specific motor impairments in the upper limb.
✕Probably not a fit
Patients with severe communication or cognitive deficits may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness and cost-effectiveness of arm-hand BOOST therapy in enhancing recovery for patients in the sub-acute phase after a stroke. Eighty patients will be recruited from two inpatient rehabilitation wards in Belgium and randomly assigned to receive either the arm-hand BOOST therapy or a control intervention, L-BOOST, alongside their usual care. The arm-hand BOOST program includes group exercises focused on neurophysiology, reaching and grasping sequences, de-weighting of the arm, and hand orientation, supplemented by technology-supported therapy. Data will be collected through standardized forms and digital platforms to assess clinical outcomes and process evaluations.
Why it matters
Potential benefit: If successful, this therapy could significantly improve upper limb recovery and overall rehabilitation outcomes for stroke patients.
How similar studies have gone: Other studies have shown promise in similar therapeutic approaches, suggesting potential for success in this intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Maximally 5 months after a first-ever unilateral, supra-tentorial stroke * Minimally 18 years old * A residual inpatient stay of minimally 4 weeks * The ability to sit independently * Motor impairment in the upper limb, as defined, based on the JSU diagram, as a score of 8-17 on stage 2 (synergies) of the Fugl-Meyer assessment upper extremity (FMA-UE) or a score of \<8 on stage 2 of the FMA-UE, combined with a score of \>6 on stage 5 (hand) of the FMA-UE. Exclusion Criteria: * Severe communication deficits as defined as a score of \<24 out of 32 on the 'visual sentence comprehension' subscale of the Comprehensive Aphasia Test. * Severe cognitive deficits as defined as a score of \<18 out of 30 on the Montreal Cognitive Assessment.
Where it's running
-
Revalidatieziekenhuis RevArte
Edegem, Antwerpen, Belgium Recruiting -
Revalidatiecentrum K7 UZ Gent
Ghent, Oost-Vlaanderen, Belgium Not yet recruiting
Study contacts
- Principal investigator: Verheyden Geert, Professor — KU Leuven
- Study coordinator: Geert Verheyden, Professor
- Email: geert.verheyden@kuleuven.be
- Phone: +32 16 32 91 16
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.